01.08.1998 | Original Article
Phase III randomized comparison of postoperative adjuvant chemotherapy with 2-year oral uracil/tegafur versus 6-cycle cyclophosphamide/methotrexate/5-fluorouracil in high-risk node-negative breast cancer patients
Erschienen in: Cancer Chemotherapy and Pharmacology | Sonderheft 1/1998
Einloggen, um Zugang zu erhalten